FDA approves blood disorder drug made by Japan's Shionogi
The U.S. Food and Drug Administration on Tuesday approved Japan-based Shionogi & Co Ltd's treatment for low blood-platelet count or thrombocytopenia in patients with chronic liver disease.

from Reuters: Health News https://ift.tt/2KelJzk
from Reuters: Health News https://ift.tt/2KelJzk
Comments
Post a Comment